Are peptides legal? Research peptide law in the US, UK, EU, Canada and Australia (2026)

Short answer: peptides themselves are not banned, but most "research peptides" sold online are unapproved medicines in the eyes of regulators once they are meant for people. Selling them for human use is illegal in all five markets below, and every regulator that has spoken on it says a "research use only" label does not change that. Approved peptide medicines, cosmetic peptides and collagen supplements are legal within their own rules.

Living in Britain? Our dedicated guide goes deeper into MHRA rules, clinic investigations and GLP-1 raids: are peptides legal in the UK?

Country by country, at a glance

Why "research use only" is not a loophole

Regulators judge a product by what it is for, not only by its label. They look at the seller's claims, website, social media, dosing information and who the product is really sold to. When that material shows a product is meant for people, the product is treated as an unapproved medicine, whatever the label says. The FDA, the MHRA, Health Canada and Australian regulators have all said this in 2026. New Zealand's Medsafe said the same in May 2026.

Real laboratory research with these compounds is legal: in-vitro and approved animal studies by institutions, using material that is not given to people.

United States

No research peptide in our library, such as BPC-157, TB-500 or MOTS-c, is an FDA-approved drug. The FDA has sent warning letters to research peptide sellers in December 2024, March, June and August 2026; our warning letters tracker lists each one with its fda.gov link. In the August letters the agency made clear that a "research use only" label does not change what a product is really sold for.

Compounding is a separate route. In April 2026 the FDA removed 12 peptides from its "Category 2" safety list after their nominations were withdrawn, and in July 2026 an advisory committee voted to recommend six peptides for the 503A list. Those votes are advisory, and the interim access policy sent for White House review on 14 October 2026 has not been published. Details: FDA peptide vote explained.

United Kingdom

The MHRA decides whether a product is a medicine by looking at its claims, its function (pharmacological, metabolic or immunological action), its intended use, comparable products and its presentation, including websites and social media. Peptides can be sold as cosmetics, supplements or medicines depending on that purpose. In April 2026 the MHRA said it disregards "research purposes" labels when they appear to be a way around medicines rules, and opened an investigation into clinics offering experimental peptide injections. Unlicensed and prescription-only medicines may not be advertised to the public.

European Union

EU law has no category called "research peptide". Under Article 1(2) of Directive 2001/83/EC, a medicinal product is any substance presented as treating or preventing disease in humans, or any substance used in or given to humans to restore, correct or modify physiological functions by pharmacological, immunological or metabolic action. A product that meets either test needs a marketing authorisation. Each member state's medicines agency enforces this, so penalties and enforcement differ across the EU.

Canada

On 9 April 2026 Health Canada warned Canadians not to buy or inject peptides sold online. It said "unauthorized drug products are illegal in Canada", that peptides are generally regulated as prescription drugs, and that "research use only" labelling "does not make these products legal or exempt from regulatory requirements". It named BPC-157, CJC-1295, DSIP, Epitalon, GHK-Cu, HCG, ipamorelin, KPV, melanotan I and II, MOTS-c, NAD+, SS-31, TB-500 and retatrutide.

Australia

Australia is the strictest of the five. BPC-157 is listed in Schedule 4 (prescription only) of the Poisons Standard and in Appendix D, which makes possession without authority illegal. Under New South Wales law, peptides including BPC-157, TB-500, CJC-1295 and ipamorelin are prescribed restricted substances; possession without a prescription can bring a fine of up to $2,200 and/or six months in prison. Personal importation requires a valid Australian prescription, and "research use only" labels do not make supply or import lawful. The TGA issued a safety advisory on unapproved peptides on 13 April 2026.

What is legal everywhere

• Approved peptide medicines such as insulin, semaglutide and tirzepatide, with a prescription. See semaglutide vs tirzepatide vs retatrutide.
• Cosmetic peptides in creams and serums, such as Argireline, Matrixyl and topical GHK-Cu.
• Collagen peptides sold as food supplements. See collagen peptides vs research peptides.
• Genuine laboratory research by institutions, with material not given to people.

Athletes face a separate rule: WADA bans BPC-157 and many other peptides at all times. Read about the risks in synthetic peptides safety risks.

This page summarises public regulator statements as of 28 October 2026. It is not legal advice; rules change, so check your national regulator.

Frequently asked questions

Sources

1. FDA: bulk drug substances that may present significant safety risks (current as of 22 Apr 2026)
2. Holland & Knight: Peptides at a crossroads, HHS and FDA actions in 2026
3. MHRA: Borderline products, how to tell if your product is a medicine (updated 2 Jul 2026)
4. Pharmacy Business: MHRA probes clinics over experimental peptide injections (7 Apr 2026)
5. Directive 2001/83/EC, Article 1 (definition of medicinal product)
6. Health Canada advisory RA-81874 (9 Apr 2026)
7. Sport Integrity Australia: BPC-157 (Poisons Standard and WADA status)
8. Law Society Journal (NSW): Injectable peptides, where does the law stand (6 Jul 2026)